Hold Glenmark Pharma for profits: Shardul Kulkarni

In a chat with ET Now, Shardul Kulkarni, Sr. Technical Analyst, Angel Broking, shares his views on Glenmark Pharma.

Have you taken a look at Glenmark Pharma this morning as well?

We have taken a look at Glenmark. This stock has achieved its price target. From a trading perspective, one should book profits. From an investment perspective, it is a very good bet going forward. We would expect even higher levels in case of Glenmark. The momentum has just begun on the monthly and the weekly charts. So any trading positions yes you can at least book partial profits but from an investment perspective, hold.